Colantuono Donato, Souied Eric H, Borrelli Enrico, Capuano Vittorio, Amoroso Francesca, Sacconi Riccardo, Jung Camille, Querques Giuseppe, Miere Alexandra
Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
Department of Ophthalmology, IRCCS San Raffaele Scientific Institute, University Vita-Salute San Raffaele, Milan, Italy.
Eur J Ophthalmol. 2021 Sep;31(5):2474-2480. doi: 10.1177/1120672120968758. Epub 2020 Nov 3.
To investigate alterations in deep retinal vascular complex (DVC) in patients with non-neovascular intermediate AMD (iAMD), treatment-naïve quiescent macular neovascularization (qMNV), exudative AMD (eAMD) by means of OCT angiography (OCTA).
Patients with iAMD, qMNV, eAMD and healthy controls presenting in the Department of Ophthalmology of the Centre Hospitalier Intercommunal de Créteil between January 2016 and January 2018, were retrospectively included. 3 × 3-mm OCTA (AngioVue RTVue XR Avanti) perfusion density (PD) of DVC was computed in all groups at baseline and follow up (12.0 ± 1.1 months).
A total of 46 eyes of 45 patients were enrolled: 11/46 iAMD, 10/46 qMNV, 13/46 eAMD, 12/46 control eyes. PD showed a significant decrease during follow-up in qMNV ( = 0.0059) and iAMD ( = 0.0076) eyes. PD in eAMD and healthy controls didn't show significant changes.
PD decreases at the level of DVC in eyes with qMNV and iAMD, while in eAMD eyes, PD is stable throughout follow up, suggesting that repeated anti-vascular endothelial growth factor (VEGF) injections do not impact on the DVC PD.
通过光学相干断层扫描血管造影(OCTA)研究非新生血管性中度年龄相关性黄斑变性(iAMD)、未经治疗的静止性黄斑新生血管(qMNV)、渗出性年龄相关性黄斑变性(eAMD)患者深层视网膜血管复合体(DVC)的变化。
回顾性纳入2016年1月至2018年1月在克雷泰伊市立中心医院眼科就诊的iAMD、qMNV、eAMD患者及健康对照者。在基线和随访(12.0±1.1个月)时计算所有组DVC的3×3 mm OCTA(AngioVue RTVue XR Avanti)灌注密度(PD)。
共纳入45例患者的46只眼:11/46为iAMD,10/46为qMNV,13/46为eAMD,12/46为对照眼。随访期间,qMNV(P = 0.0059)和iAMD(P = 0.0076)眼的PD显著降低。eAMD和健康对照者的PD无显著变化。
qMNV和iAMD眼DVC水平的PD降低,而eAMD眼在整个随访过程中PD稳定,提示反复抗血管内皮生长因子(VEGF)注射对DVC的PD无影响。